Back to AGN Stock Lookup

Allergan (AGN) – Credit Ratings

Aug 9, 2016 10:27 AM S&P Upgrades Allergan (AGN) to 'BBB'; Removes from CreditWatch
Jul 13, 2016 12:48 PM S&P Downgrades Teva Pharma (TEVA) to 'BBB'; Outlook is Stable (AGN)
Jun 29, 2016 09:15 AM S&P Upgrades Allergan (AGN) to 'BBB-'; Outlook Stable
Apr 14, 2016 11:11 AM Moody's Sees Allergan's (AGN) Use of Cash Following Generics Divestiture as Key to Credit Profile
Apr 6, 2016 04:51 PM Allergan (AGN) Ratings Affirmed by Moody's Amid Scrubbed Deal with Pfizer
Nov 23, 2015 03:45 PM Moody's Sees Lower Cash Levels for Pfizer (PFE) as Shareholder Payouts Increase Amid Allergan (AGN) Deal
Nov 23, 2015 12:09 PM S&P Places Pfizer (PFE) on Watch for Downgrade Following Move to Acquire Allergan (AGN)
Nov 4, 2015 03:06 PM Moody's Likely to Downgrade Teva Pharma (TEVA) Amid Allergan Deal
Oct 30, 2015 11:34 AM Pfizer (PFE), Allergan (AGN) Deal Not Atypical to U.S. Branded Pharma Industry - Fitch
Oct 29, 2015 11:45 AM Moody's Sees Potential Pfizer/Allergan Deal as Credit-Positive Development (PFE) (AGN)
Mar 17, 2015 12:35 PM Fitch Downgrades Allergan (AGN) to 'BBB-'; Removes from Watch Negative (ACT)
Nov 21, 2014 02:16 PM Moody's Revises Outlook on Valeant Pharma (VRX) to Stable; Affirms Ratings
Nov 17, 2014 12:10 PM Fitch Affirms Ratings on Actavis (ACT) Following Allergan (AGN) Bid
Sep 23, 2014 12:24 PM Actavis plc (ACT) Credit (Cash) Downgraded at BofA/Merrill Lynch
May 28, 2014 03:39 PM Valeant's (VRX) Revised Offer for Allergan (AGN) is Credit-Positive Development - Moody's
Apr 22, 2014 02:46 PM Moody's Moves Outlook on Valeant Pharma (VRX) to 'Developing'; Affirms Existing Ratings (AGN)

Back to AGN Stock Lookup